home / stock / exai / exai news


EXAI News and Press, Exscientia Limited From 05/18/24

Stock Information

Company Name: Exscientia Limited
Stock Symbol: EXAI
Market: NASDAQ
Website: exscientia.ai

Menu

EXAI EXAI Quote EXAI Short EXAI News EXAI Articles EXAI Message Board
Get EXAI Alerts

News, Short Squeeze, Breakout and More Instantly...

EXAI - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Exscientia

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Exscientia To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 18, 2024) - Faruqi & Faruqi, LLP, a leading national ...

EXAI - Exscientia to Report First Quarter 2024 Financial Results on May 21, 2024

Company to host conference call and webcast on May 21, 2024, at 1:30 p.m. BST / 8:30 a.m. EDT Exscientia plc (Nasdaq: EXAI) will report financial results for the first quarter ended March 31, 2024, on Tuesday, May 21, 2024, before the open of U.S. markets. The Company will host a confer...

EXAI - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Exscientia

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Exscientia To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 12, 2024) - Faruqi & Faruqi, LLP, a leading national ...

EXAI - AI-discovered drugs have an 80%-90% success rate: study

2024-05-10 14:13:46 ET More on Alphabet, Recursion, etc. Recursion Pharmaceuticals, Inc. (RXRX) Q1 2024 Earnings Call Transcript Bronte Capital - Alphabet: Could Not Find Anything We Liked More Google: The Recent Surge Is Far From Over CrowdStrike, Google exp...

EXAI - SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Exscientia

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Exscientia To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 7, 2024) - Faruqi & Faruqi, LLP, a leading national s...

EXAI - Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 25, 2024 in Exscientia plc Lawsuit - EXAI

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 25, 2024 in Exscientia plc Lawsuit - EXAI Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 25, 2024 in Exscientia plc Lawsuit - EXAI PR Newswire NEW YORK , ...

EXAI - EXSCIENTIA DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Exscientia

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Exscientia To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 5, 2024) - Faruqi & Faruqi, LLP, a leading national s...

EXAI - Anatomy Of An AI Correction

2024-05-02 13:05:00 ET Summary The AI ecosystem comprises semiconductors, software, other hardware and innovative use cases, all of which play crucial roles in the advancement and adoption of AI. Realistic expectations for 2024 include the potential for a hardware refresh cycle dr...

EXAI - AVPT, PI and MXL are among after hour movers

2024-04-24 17:41:05 ET Gainers: Acrivon Therapeutics ( ACRV ) +19% . Impinj ( PI ) +10% . Exscientia  ( EXAI ) +6% . Churchill Downs  ( CHDN ) +5% . PowerFleet ( PWFL ) +5% . Losers: Meta Platforms ( META ) ...

EXAI - Moderna and OpenAI in pact to fast-track drug development

2024-04-24 09:19:50 ET More on Moderna Moderna Investors Should Beware Patent-Dispute Fallout Moderna: Considering The Cancer Vaccine Angle Moderna Continues To Build A Pipeline S&P 500 stocks with biggest estimated EPS declines for Q1 Moderna sto...

Previous 10 Next 10